Pharma Journalist - Page 823 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

SpinalCyte’s CybroCell Dermal Fibroblasts signals positive Phase 1/2 Clinical Trial Results

MOLOGEN forays into global co-development agreement with ONCOLOGIE for lead compound lefitolimod

Exelixis declares results from Phase 2 IST of Cabozantinib treating RAI-DTC

Merck overturns APECS Study assessing Verubecestat (MK-8931) for Prodromal Alzheimer’s Disease

EC sanctions Celltrion’s Herzuma for breast Cancer patients

Challenges in drug-delivery device pipelines for pharma companies

Horizon Discovery enters into License Agreement with US Immuno-Oncology Company

DNAnexus Launches NGS Clinical Trial Solution

Applied Therapeutics Initiates Phase 1 Trial for AT-001 In Diabetic Complications

Teva announces Launch of a Generic Version of Syprine in the United States